NIR Diagnostics Inc.
NIR Diagnostics Inc. (NIR) is engaged in the research and development of diagnostic medical instruments. It utilizes light based technology instead of chemical reagents to monitor blood analytes. Its in-vitro technologies developed by the company include HemoNIR, CardioNIR and LiproNIR. The company owns various optical, electronic and algorithm related patents for medical applications. The company is headquartered in Ontario, Canada.The company reported revenues of (Canadian Dollars) CAD 1.95 million during the fiscal year ended December 2007, an increase of 220.59% over 2006. The operating loss of the company was CAD 2.18 million during the fiscal year 2007, as compared to an operating loss of CAD 2.40 million during 2006. The net loss of the company was CAD 2.18 million during the fiscal year 2007, as compared to a net loss of CAD 2.40 million during 2006.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

